Ausdal Financial Partners, Inc. Guardant Health, Inc. Transaction History
Ausdal Financial Partners, Inc.
- $1.1 Billion
- Q4 2024
A detailed history of Ausdal Financial Partners, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Ausdal Financial Partners, Inc. holds 7,000 shares of GH stock, worth $328,860. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,000Holding current value
$328,860% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding GH
# of Institutions
343Shares Held
123MCall Options Held
846KPut Options Held
2.23M-
Vanguard Group Inc Valley Forge, PA12.1MShares$566 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$528 Million0.01% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$326 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$302 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$256 Million0.13% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.8B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...